Work

Baseline predictors of hematological toxicity in patients with advanced cancer treated with ATR inhibitors in phase I/II clinical trials.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.3111

Authors: Natalie Ngoi, Heather Y. Lin, Ecaterina Elena Dumbrava, Siqing Fu, Daniel D. Karp, Aung Naing, Shubham Pant, Sarina Anne Piha-Paul, Jordi Rodon Ahnert, Vivek Subbiah, Apostolia Maria Tsimberidou, Erick Campbell, Samuel Urrutia, David S. Hong, Funda Meric-Bernstam, Ying Yuan, Timothy A. Yap

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286293754

Cites:

Cited by: 10

Related to: 10